Miki Ando

Juntendo University — Japan

Medicine · Health Sciences

14h-index695citations132works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(24), Lung Cancer Research Studies(24), Lymphoma Diagnosis and Treatment(20), Acute Myeloid Leukemia Research(18), Myeloproliferative Neoplasms: Diagnosis and Treatment(18)

Publications132 total

Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia
International Journal of Hematology·2025· 1 cited
Anti-tumor effect of a histone deacetylase inhibitor on canine malignant melanoma
Journal of Veterinary Medical Science·2025Open Access
Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron Era
Clinical Lymphoma Myeloma & Leukemia·2025· 1 cited
A retrospective analysis of clinicopathological and genetic features of synchronous CNS and systemic DLBCL at diagnosis
International Journal of Hematology·2025
A New Histology-Based Prognostic Index for Acute Lymphoblastic Leukemia (Urayasu Classification for ALL) and a Review of the Literature on Drug Resistance Induced by Functional Proteins in Hematologic Malignancies
Preprints.org·2025Open Access
Application of Convolutional Neural Network Image Analysis and Machine Learning to Basic Blood Tests for Intelligent Diagnostic Assistance
International Journal of Laboratory Hematology·2025
The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Cardio-Oncology·2025Open Access
Artificial intelligence-driven label-free detection of chronic myeloid leukemia cells using ghost cytometry
Scientific Reports·2025· 3 citedOpen Access
Early Epcoritamab Administration Revives CAR‐T Cells in Relapsed/Refractory B‐Cell Lymphomas
eJHaem·2025Open Access
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution
International Journal of Hematology·2025· 3 cited
Immune recovery in tumor microenvironment of <i>TP53</i> -mutated AML following venetoclax combination therapy
2025Open Access
Generation of iPSC-derived CD4 <sup>+</sup> Th1 cells enhancing chimeric antigen receptor-T cell cytotoxicity
2025Open Access
A New Histology-Based Prognostic Index for Acute Myeloid Leukemia: Preliminary Results for the “AML Urayasu Classification”
Journal of Clinical Medicine·2025Open Access
Molecular Mechanisms by Which Polyunsaturated Fatty Acids Suppress the Pathogenesis and Progression of NAFLD
YAKUGAKU ZASSHI·2025· 1 citedOpen Access
A New Histology-based Prognostic Index for Acute Myeloid leukemia: Preliminary results for the "AML Urayasu Classification "
Preprints.org·2025· 1 citedOpen Access
[What is needed now to develop female leaders].
PubMed·2025
[iPSC-derived next-generation T cell therapy for refractory malignancies].
PubMed·2025
Effects of trastuzumab emtansine on canine osteosarcoma cells
Journal of Veterinary Medical Science·2025· 1 citedOpen Access
<i>BCR::ABL1</i>‐induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia
Cancer Science·2024· 5 citedOpen Access
Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates
International Journal of Hematology·2024
page 1 of 7Next →

Frequent Co-authors

Jun Ando(24), Norio Komatsu(22), Shintaro Kinoshita(13), Midori Ishii(11), Yoshiki Furukawa(11), Shuichi Shirane(11), Hajime Yasuda(11), Hiromitsu Nakauchi(10), Tadaaki Inano(9), Tomonori Ochiai(9), Tomoiku Takaku(9), Kazuo Oshimi(7), Yoko Azusawa(7), Yoko Edahiro(7), Koichi Ohshima(6), Soji Morishita(6), Yutaka Tsukune(6), Naoki Watanabe(6), Koichi Sugimoto(5), Makoto Sasaki(5)